There are two main complementary findings highlighted in this study: 1) a positive association between OGN and improved survival in primary CRC tumors; and 2) reduced activation of EGFR/AKT/Zeb-1 in colorectal cancer cells when OGN over-expressed. This evidence concerns the gene AKT1 and colorectal cancer.